News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
273,154 Results
Type
Article (14089)
Company Profile (102)
Press Release (258963)
Multimedia
Podcasts (47)
Webinars (10)
Section
Business (89607)
Career Advice (466)
Deals (15734)
Drug Delivery (67)
Drug Development (37190)
Employer Resources (49)
FDA (6433)
Job Trends (6274)
News (153004)
Policy (14298)
Tag
Academia (452)
Accelerated approval (2)
Adcomms (6)
Allergies (38)
Alliances (23994)
ALS (39)
Alzheimer's disease (400)
Antibody-drug conjugate (ADC) (47)
Approvals (6468)
Artificial intelligence (117)
Autoimmune disease (9)
Automation (5)
Bankruptcy (149)
Best Places to Work (4430)
BIOSECURE Act (9)
Biosimilars (58)
Biotechnology (40)
Bladder cancer (22)
Brain cancer (16)
Breast cancer (92)
Cancer (679)
Cardiovascular disease (74)
Career advice (410)
Career pathing (12)
CAR-T (23)
Cell therapy (93)
Cervical cancer (4)
Clinical research (31472)
Collaboration (377)
Compensation (169)
Complete response letters (17)
COVID-19 (773)
CRISPR (23)
C-suite (135)
Cystic fibrosis (40)
Data (723)
Denatured (15)
Depression (10)
Diabetes (85)
Diagnostics (1414)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (61)
Drug pricing (70)
Drug shortages (12)
Duchenne muscular dystrophy (39)
Earnings (32757)
Editorial (14)
Employer branding (4)
Employer resources (43)
Events (38255)
Executive appointments (412)
FDA (6936)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (234)
Gene editing (42)
Generative AI (9)
Gene therapy (106)
GLP-1 (356)
Government (1322)
Grass and pollen (3)
Guidances (69)
Healthcare (3752)
Huntington's disease (4)
IgA nephropathy (13)
Immunology and inflammation (40)
Indications (14)
Infectious disease (808)
Inflammatory bowel disease (58)
Inflation Reduction Act (6)
Influenza (14)
Intellectual property (51)
Interviews (60)
IPO (5974)
IRA (29)
Job creations (2066)
Job search strategy (374)
Kidney cancer (6)
Labor market (14)
Layoffs (183)
Leadership (4)
Legal (3521)
Liver cancer (19)
Lung cancer (90)
Lymphoma (58)
Machine learning (4)
Management (16)
Manufacturing (180)
MASH (35)
Medical device (1432)
Medtech (1434)
Mergers & acquisitions (9983)
Metabolic disorders (272)
Multiple sclerosis (22)
NASH (14)
Neurodegenerative disease (26)
Neuropsychiatric disorders (8)
Neuroscience (598)
NextGen: Class of 2025 (1611)
Non-profit (596)
Now hiring (8)
Obesity (153)
Opinion (119)
Ovarian cancer (22)
Pain (59)
Pancreatic cancer (17)
Parkinson's disease (48)
Partnered (7)
Patents (131)
Patient recruitment (31)
Peanut (10)
People (29339)
Pharmaceutical (64)
Pharmacy benefit managers (12)
Phase I (8239)
Phase II (13330)
Phase III (11899)
Pipeline (559)
Policy (74)
Postmarket research (1427)
Preclinical (3302)
Press Release (25)
Prostate cancer (51)
Psychedelics (8)
Radiopharmaceuticals (125)
Rare diseases (179)
Real estate (2698)
Recruiting (17)
Regulatory (10325)
Reports (14)
Research institute (580)
Resumes & cover letters (55)
Rett syndrome (1)
RNA editing (2)
RSV (8)
Schizophrenia (39)
Series A (42)
Series B (16)
Service/supplier (4)
Sickle cell disease (32)
Special edition (6)
Spinal muscular atrophy (77)
Sponsored (6)
Startups (1671)
State (2)
Stomach cancer (3)
Supply chain (33)
Tariffs (39)
The Weekly (30)
Vaccines (162)
Venture capitalists (14)
Weight loss (101)
Women's health (8)
Worklife (4)
Date
Today (70)
Last 7 days (343)
Last 30 days (1119)
Last 365 days (11868)
2025 (4438)
2024 (12721)
2023 (14535)
2022 (20466)
2021 (20944)
2020 (19645)
2019 (15254)
2018 (11938)
2017 (14222)
2016 (13421)
2015 (15858)
2014 (12716)
2013 (10822)
2012 (11682)
2011 (12164)
2010 (11098)
Location
Africa (314)
Alabama (13)
Alaska (1)
Arizona (59)
Arkansas (3)
Asia (20463)
Australia (2734)
California (1889)
Canada (967)
China (257)
Colorado (72)
Connecticut (74)
Delaware (64)
Europe (42559)
Florida (365)
Georgia (40)
Idaho (10)
Illinois (210)
India (16)
Indiana (142)
Iowa (1)
Japan (106)
Kansas (60)
Kentucky (13)
Louisiana (2)
Maine (2)
Maryland (279)
Massachusetts (1647)
Michigan (33)
Minnesota (100)
Missouri (23)
Montana (8)
Nebraska (6)
Nevada (9)
New Hampshire (6)
New Jersey (832)
New Mexico (7)
New York (555)
North Carolina (415)
North Dakota (2)
Northern California (790)
Ohio (51)
Oklahoma (4)
Oregon (16)
Pennsylvania (494)
Puerto Rico (8)
Rhode Island (10)
South America (507)
South Carolina (3)
Southern California (787)
Tennessee (36)
Texas (251)
United States (7888)
Utah (38)
Virginia (81)
Washington D.C. (32)
Washington State (127)
Wisconsin (20)
273,154 Results for "biofrontera pharmaceuticals gmbh".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Biofrontera Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 21, 2025
March 12, 2025
·
1 min read
Genetown
Biofrontera Inc. Announces Restructuring of Supply Agreement with Biofrontera AG
Biofrontera Inc. today announced the restructuring of agreements between the Company and its former parent company Biofrontera AG.
February 20, 2024
·
5 min read
Business
Biofrontera Inc. Reports First Quarter 2024 Financial Results and Provides a Business Update
Biofrontera Inc., a biopharmaceutical company specializing in the commercialization of dermatologic products, reported financial results for the three months ended March 31, 2024 and provided a business update.
May 15, 2024
·
11 min read
Genetown
Biofrontera Announces the Launch of a New, FDA-Approved Red Light Source, the RhodoLED® XL Lamp
Biofrontera Inc. (NASDAQ: BFRI), a biopharmaceutical company specializing in the commercialization of dermatologic products, is proud to announce the launch of its FDA-approved RhodoLED XL, a red light emitting LED lamp.
June 24, 2024
·
5 min read
Press Releases
Biofrontera Inc. Announces 100 RhodoLED® XL Machines Now Placed in US Market
December 23, 2024
·
5 min read
Press Releases
Sirona Biochem Secures Strategic Investment Agreements and New Joint Venture with Promura GmbH
April 22, 2025
·
6 min read
Business
Biofrontera Inc. Reports Record Fiscal Year 2023 Financial Results and Provides a Business Update
Biofrontera, Inc. today reported financial results for the three and twelve months ended December 31, 2023.
March 15, 2024
·
14 min read
Business
Biofrontera Inc. to Report First Quarter 2024 Financial Results on May 15, 2024
Biofrontera Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, today announced that it will report financial results for the three months ended March 29, 2024 on Wednesday, May 15, 2024.
May 6, 2024
·
1 min read
Press Releases
Biofrontera Inc. Closes a $4.2 Million Senior Secured Convertible Note
November 25, 2024
·
3 min read
Press Releases
Biofrontera Inc. to Present at The Benchmark Company’s Upcoming Discovery One-on-One Investor Conference
December 3, 2024
·
4 min read
1 of 27,316
Next
